Aaron Jesky, Sr. Cloud Architect In the fascinating and high-stakes domain of biotechnology, research validation and acquisition of the next wave of funding stand as crucial checkpoints in the journey of a startup. Amid an environment characterized by...
By Scott Scheirey AWS re:Invent 2022 had over 50,000 attendees eagerly awaiting the latest releases that will ultimately push cloud innovation in years to come. Amazon releases thousands of ‘significant services and features’ every year, which ultimately transform the...
Due to the high volume of R&D involved in software design and development processes in Life Sciences and Biotechnology, companies in this sector are ideal candidates to claim R&D Tax Credits. A portion of investment in activities, like developing and testing...
In this edition of the PTP Infinite Innovation Interview series, PTP’s Life Sciences Lead, Bill Amsbaugh, discusses a case study to improve treatment development for a Therapeutics firm. ...
